Presentation is loading. Please wait.

Presentation is loading. Please wait.

Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study  Erik Thunnissen, MD, PhD, Masayuki.

Published byDubravka Šuklje Modified over 6 years ago

Similar presentations

Presentation on theme: "Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study  Erik Thunnissen, MD, PhD, Masayuki."— Presentation transcript:

1 Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study  Erik Thunnissen, MD, PhD, Masayuki Noguchi, MD, Seena Aisner, MD, Mary Beth Beasley, MD, Elisabeth Brambilla, MD, PhD, Lucian R. Chirieac, MD, Jin-Haeng Chung, MD, PhD, Sanja Dacic, MD, Kim R. Geisinger, MD, Fred R. Hirsch, MD, PhD, Yuichi Ishikawa, MD, PhD, Keith M. Kerr, MD, PhD, Sylvie Lantejoul, MD, PhD, Yoshiro Matsuno, MD, Yuko Minami, MD, Andre L. Moreira, MD, Giuseppe Pelosi, MD, Iver Petersen, MD, PhD, Victor Roggli, MD, William D. Travis, MD, Ignacio Wistuba, MD, Yasushi Yatabe, MD, PhD, Rafal Dziadziuszko, MD, PhD, Birgit Witte, PhD, Ming-Sound Tsao, MD, FRCPC, Andrew G. Nicholson, DM  Journal of Thoracic Oncology  Volume 9, Issue 9, Pages (September 2014) DOI: /JTO Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 A flow chart for the application of histological criteria in poorly differentiated SqCC based on the WHO classification HPF, high power field; NUT, NUT midline carcinoma, family member 1 (NUTM1); SqCC, squamous cell carcinoma; WHO, World Health Organization. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Example of consensus squamous cell carcinoma. A, Overview, ×20 (B), example of spindle cells in diffuse architecture (no nests or fields) (C), consensus score for lymphocytic infiltrate between the tumor cells (D), For palisading, no consensus was obtained: 25% of the pathologists called this palisading (E), detailed images with around the centered cell in at least part of the perimeter features of intercellular bridges (F, G), detailed images with three examples of intercellular gaps (called by most pathologists) (H–J), example of intracytoplasmic vacuole (arrow, consensus by all the pathologists) (K). Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study  Erik Thunnissen, MD, PhD, Masayuki."

Similar presentations

A RETROSPECTIVE ANALYSIS OF FREQUENCY OF ALK GENE

A RETROSPECTIVE ANALYSIS OF FREQUENCY OF ALK GENE
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth.
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer  Anne S. Tsao, MD, Xi Ming Tang, MD, PhD, Bradley Sabloff, MD,

Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer  Anne S. Tsao, MD, Xi Ming Tang, MD, PhD, Bradley Sabloff, MD,
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart  William D. Travis, MD, Elisabeth Brambilla,

Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart  William D. Travis, MD, Elisabeth Brambilla,
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic.

Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic.
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,

Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,
Ugonna N. Ihekweazu, BS, William D. Travis, MD, Raja M. Flores, MD 

Ugonna N. Ihekweazu, BS, William D. Travis, MD, Raja M. Flores, MD 
The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study.

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study.
The 2015 World Health Organization Classification of Lung Tumors

The 2015 World Health Organization Classification of Lung Tumors
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
ALK FISH and IHC: You Cannot Have One without the Other

ALK FISH and IHC: You Cannot Have One without the Other
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors  Neal I. Lindeman,

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors  Neal I. Lindeman,
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors  Neal I. Lindeman,

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors  Neal I. Lindeman,
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K

Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
Ming-Sound Tsao, MD, FRCPC, William D

Ming-Sound Tsao, MD, FRCPC, William D

Similar presentations

Ads by Google